Chinese medical technology company Stoke Medical raised nearly hundreds of millions of yuan in a series B round funding Led by Hidea Captial, and followed by Share Win Investment and Grand Yangtze Capital. The investment will be used on clinical advance and new product promotion and industrialization.
Established in 2016, Stoke Medical focuses on developing mild and minimal intervention products that prevent and treat cerebral ischemic stroke. It has four product lines including cerebral stroke prevention, acute stoke clot removal, stoke purification, and stoke narrow treatment.
South Africa Today